Cargando…

HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial

BACKGROUND: Cervical cancer screening participation is suboptimal in most settings. We assessed whether human papillomavirus (HPV) self-sampling may increase screening participation among long-term non-attenders in Norway. METHODS: A pragmatic randomised controlled trial with participation as the pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aasbø, Gunvor, Tropè, Ameli, Nygård, Mari, Christiansen, Irene Kraus, Baasland, Ingrid, Iversen, Grete Alrek, Munk, Ane Cecilie, Christiansen, Marit Halonen, Presthus, Gro Kummeneje, Undem, Karina, Bjørge, Tone, Castle, Philip E., Hansen, Bo T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643532/ https://www.ncbi.nlm.nih.gov/pubmed/35995936 http://dx.doi.org/10.1038/s41416-022-01954-9

Ejemplares similares

Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study
por: Aasbø, Gunvor, et al.
Publicado: (2019)

Randomized Implementation of a Primary Human Papillomavirus Testing–based Cervical Cancer Screening Protocol for Women 34 to 69 Years in Norway
por: Nygård, Mari, et al.
Publicado: (2022)

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
por: Hashim, Dana, et al.
Publicado: (2020)

Unpacking the Lay Epidemiology of Cervical Cancer: A Focus Group Study on the Perceptions of Cervical Cancer and Its Prevention among Women Late for Screening in Norway
por: Aasbø, Gunvor, et al.
Publicado: (2023)

Implementing medical abortion with mifepristone and misoprostol in Norway 1998–2013
por: Løkeland, Mette, et al.
Publicado: (2017)

Barriers to cervical cancer screening faced by immigrants: a registry-based study of 1.4 million women in Norway
por: Leinonen, Maarit K., et al.
Publicado: (2017)

Searching for “transformative moments”: A qualitative study of nurses’ work during home visits to COPD patients and their caregivers in Norway
por: Aasbø, Gunvor, et al.
Publicado: (2018)

Combining Mass Cytometry Data by CyTOFmerge Reveals Additional Cell Phenotypes in the Heterogeneous Ovarian Cancer Tumor Microenvironment: A Pilot Study
por: Thomsen, Liv Cecilie Vestrheim, et al.
Publicado: (2023)

‘It’s not just about me’: a qualitative study of couples’ narratives about home death when one of the partners is dying of cancer
por: Aurén-Møkleby, Margareta, et al.
Publicado: (2023)

FightHPV: Design and Evaluation of a Mobile Game to Raise Awareness About Human Papillomavirus and Nudge People to Take Action Against Cervical Cancer
por: Ruiz-López, Tomás, et al.
Publicado: (2019)

Cervical cancer mortality in Norway according to screening attendance and age
por: Baasland, Ingrid, et al.
Publicado: (2022)

Primary Treatment Effects for High-Grade Serous Ovarian Carcinoma Evaluated by Changes in Serum Metabolites and Lipoproteins
por: Torkildsen, Cecilie Fredvik, et al.
Publicado: (2023)

Impact of the Mobile Game FightHPV on Cervical Cancer Screening Attendance: Retrospective Cohort Study
por: Orumaa, Madleen, et al.
Publicado: (2022)

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention
por: Lönnberg, Stefan, et al.
Publicado: (2016)

CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
por: Vedeld, Hege Marie, et al.
Publicado: (2017)

Cervical cancer in women under 30 years of age in Norway: a population-based cohort study
por: Gravdal, Brit Helene, et al.
Publicado: (2021)

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
por: Bjørge, T, et al.
Publicado: (2004)

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
por: Engesæter, Birgit, et al.
Publicado: (2016)

Quality assessment of the registration of vulvar and vaginal premalignant lesions at the Cancer Registry of Norway
por: Enerly, Espen, et al.
Publicado: (2012)

Reproductive factors and prognosis of uterine cervical cancer in Norway.
por: Bjørge, T., et al.
Publicado: (1996)

Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
por: Tsuruda, Kaitlyn M, et al.
Publicado: (2021)

Fostering Prevention of Cervical Cancer by a Correct Diagnosis of Precursors: A Structured Case-Based Colposcopy Course in Finland, Norway and UK
por: Sabrina, Forsell, et al.
Publicado: (2020)

An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway
por: Enerly, Espen, et al.
Publicado: (2019)

Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway
por: Engeland, Anders, et al.
Publicado: (2011)

Evaluating a system-wide, safety investigation in healthcare course in Norway: a qualitative study
por: Haraldseid-Driftland, Cecilie, et al.
Publicado: (2022)

Shared decision‐making in standardized cancer patient pathways in Norway—Narratives of patient experiences
por: Andersen‐Hollekim, Tone, et al.
Publicado: (2021)

Health-Related Quality of Life Trajectories across 10 Years after Moderate to Severe Traumatic Brain Injury in Norway
por: Forslund, Marit V., et al.
Publicado: (2021)

Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010–2011: A National Prospective Case-Control Study
por: MacDonald, Emily, et al.
Publicado: (2015)

Colposcopy and additive diagnostic value of biopsies from colposcopy‐negative areas to detect cervical dysplasia
por: Baasland, Ingrid, et al.
Publicado: (2016)

HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway
por: Budal, Elisabeth B, et al.
Publicado: (2014)

First Human Cases of Tickborne Encephalitis, Norway
por: Skarpaas, Tone, et al.
Publicado: (2004)

Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
por: Grindedal, Eli Marie, et al.
Publicado: (2020)

Validation of maternal reported pregnancy and birth characteristics against the Medical Birth Registry of Norway
por: Skulstad, Svein Magne, et al.
Publicado: (2017)

The ‘Finnish new variant of Chlamydia trachomatis’ escaping detection in the Aptima Combo 2 assay is widespread across Norway, June to August 2019
por: Johansen, Tone Bjordal, et al.
Publicado: (2019)

A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
por: Heger, Katrine, et al.
Publicado: (2020)

Trends for invasive squamous cell neoplasia of the skin in Norway
por: Iversen, T, et al.
Publicado: (1999)

Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
por: Helland, Åslaug, et al.
Publicado: (2022)

Effects of pH on steam explosion extraction of acetylated galactoglucomannan from Norway spruce
por: Michalak, Leszek, et al.
Publicado: (2018)

COVID-19 and psychological distress in Norway: The role of trust in the healthcare system
por: Harris, Samantha M., et al.
Publicado: (2020)

Farm-based day care in Norway – a complementary service for people with dementia
por: Ibsen, Tanja Louise, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9gjdm2nurah9laoqq8flgs30i6